The proof-of-concept study is one of the first to combine B and T cell analysis and potentially paves the way for tests that ...

Unity Software (U) shares experienced a dramatic increase of over 30% after the game engine company reported fourth-quarter ...

Video game engine company Unity (NYSE: U) reported fourth-quarter results that should make investors squirm. Total revenue ...

Morgan Stanley raised the firm’s price target on Unity (U) to $32 from $26 and keeps an Overweight rating on the shares. Unity will start ...

Unity Software Inc. beats earnings expectations, fueling a 45% stock rally. Click here to find out why U stock is a Strong ...

Wall Street analysts rerated Unity Software Inc (NYSE:U) after the company reported an upbeat quarterly result Thursday amid an exciting earnings season. Unity’s fourth-quarter revenue decreased 25% ...

Kennesaw State University undergraduate researchers participate in Posters at the Capitol in Atlanta, hosted by the Georgia Undergraduate Research Collective. The event provides undergraduate students ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

Consumer Analyst Group of New York Conference (CAGNY) 2025 February 21, 2025 8:00 AM ETCompany ParticipantsNoel ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners ...

Find insight on Booking Holdings, AppLovin, Dye & Durham, and more in the latest Market Talks covering Technology, Media and Telecom.